Literature DB >> 9014137

Modulation of human recombinant GABAA receptors by pregnanediols.

D Belelli1, J J Lambert, J A Peters, K W Gee, N C Lan.   

Abstract

Utilising two point voltage-clamp techniques on Xenopus laevis oocytes expressing human (alpha 1 beta 1 gamma 2L) recombinant GABAA receptors, the GABA modulatory actions of six naturally occurring neurosteroids have been determined and compared with those of known positive allosteric modulators. The anaesthetic steroids 5 alpha- and 5 beta-pregnan-3 alpha-ol-20-one produced a concentration-dependent enhancement of the GABA-evoked current. The maximal enhancement of the agonist-induced response produced by these steroids was intermediate between that of pentobarbitone and diazepam, but much greater than that caused by bretazenil. For both the 5 alpha and 5 beta steroid a reduction of the 20 ketone group to form either the corresponding 20 alpha or 20 beta hydroxy steroid produced, in all cases, a reduction in potency and a decrease in the maximal effect. The relationship of steroid structure to these two parameters is considered. The influence of the alpha subtype (alpha x beta 1 gamma 2L, where x = 1, 2 or 3) for the behaviourally active 5 alpha-pregnan-3 alpha,20 alpha-diol is also determined. Although the maximal effect of the steroid is not influenced by the alpha subtype, the alpha 2-containing receptor exhibits a modest decrease (approximately 6-fold) in potency compared to alpha 1- and alpha 3-containing receptors. The results described here are discussed in relation to the distinct behavioural actions of the neurosteroids.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9014137     DOI: 10.1016/s0028-3908(96)00066-4

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Oxytocin regulates neurosteroid modulation of GABA(A) receptors in supraoptic nucleus around parturition.

Authors:  Jan-Jurjen Koksma; Ronald E van Kesteren; Thomas W Rosahl; Ruud Zwart; August B Smit; Hartmut Lüddens; Arjen B Brussaard
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

2.  α4βδ GABAA receptors reduce dendritic spine density in CA1 hippocampus and impair relearning ability of adolescent female mice: Effects of a GABA agonist and a stress steroid.

Authors:  Sonia Afroz; Hui Shen; Sheryl S Smith
Journal:  Neuroscience       Date:  2017-02-09       Impact factor: 3.590

3.  Effects of a naturally occurring neurosteroid on GABAA IPSCs during development in rat hippocampal or cerebellar slices.

Authors:  E J Cooper; G A Johnston; F A Edwards
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

4.  A single amino acid confers barbiturate sensitivity upon the GABA rho 1 receptor.

Authors:  D Belelli; D Pau; G Cabras; J A Peters; J J Lambert
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

Review 5.  Aging, hormones and receptors.

Authors:  M Hill; Z Třískala; P Honců; M Krejčí; J Kajzar; M Bičíková; L Ondřejíková; D Jandová; I Sterzl
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

6.  Photoaffinity labeling identifies an intersubunit steroid-binding site in heteromeric GABA type A (GABAA) receptors.

Authors:  Selwyn S Jayakar; David C Chiara; Xiaojuan Zhou; Bo Wu; Karol S Bruzik; Keith W Miller; Jonathan B Cohen
Journal:  J Biol Chem       Date:  2020-06-15       Impact factor: 5.157

Review 7.  Steroids in Stroke with Special Reference to Progesterone.

Authors:  Rachida Guennoun; Xiaoyan Zhu; Magalie Fréchou; Pauline Gaignard; Abdelhamid Slama; Philippe Liere; Michael Schumacher
Journal:  Cell Mol Neurobiol       Date:  2018-10-09       Impact factor: 5.046

8.  Increased Dendritic Branching of and Reduced δ-GABAA Receptor Expression on Parvalbumin-Positive Interneurons Increase Inhibitory Currents and Reduce Synaptic Plasticity at Puberty in Female Mouse CA1 Hippocampus.

Authors:  Hui Shen; Lindsay Kenney; Sheryl S Smith
Journal:  Front Cell Neurosci       Date:  2020-07-09       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.